Search

everythinglearnresearchcommunity

for

Search:↓

PRP therapy can be effective for early-stage common hair loss, with most patients seeing improvement, but there are inconsistencies in treatment methods.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

15.33% of young Caucasian men have severe hair loss, with higher rates in Jewish men and links to age, BMI, and possibly metabolic syndrome.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Dutasteride is more effective than finasteride for hair growth with similar side effects.

Men with genetic hair loss are more likely to have abnormal blood lipid levels, especially if the hair loss is severe.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Male-pattern hair loss is normal, often involves hormone effects on hair follicles, and can be treated with medication or surgery, but new treatments are being researched.

Microneedling combined with platelet-rich plasma therapy is more effective for hair regrowth in androgenic alopecia than microneedling alone, but it's more painful.

Finasteride doesn't negatively affect sexual function in Indian men with hair loss.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

Minoxidil can treat hair loss with topical, oral, and sublingual options, offering personalized choices.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Low-dose oral minoxidil improves hair growth in male hair loss.

Baldness score can't be used to predict prostate size.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Chinese men have lower AGA rates than Caucasians, with type III vertex most common; family history is important.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Hair transplants are effective for male and female pattern baldness, have evolved in technique, and require careful planning for natural results and managing complications.

DSC cell injections significantly improved hair density and diameter, showing potential as a hair loss treatment.

MC4R gene variants not linked to female hair loss.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Oral minoxidil improved hair loss more than oral dutasteride.